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ABBREVIATIONS 
FNAC - Fine needle aspiration cytology 
FNNAC - Fine needle non-aspiration cytology 
T3 – Triiodothyronine 
T4 - Thyroxine  
TSH - Thyroid stimulating hormone  
TRH - Thyrotropin releasing hormone 
SNT - Solitary nodule of thyroid  
MNG – Multinodular goitre  
CNG - Colloid nodular goitre 
CG - Colloid goitre  
Pap Ca - Papillary carcinoma 
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INTRODUCTION 
The Thyroid gland is  unique among the endocrine glands because of  its  
larger size and  superficial  location ,which makes  it  easily accessible 
for direct physical, cytological and histopathological examination. 
In clinical practice,diseases of  the thyroid gland due to developmental, 
inflammatory, infectious, hyperplastic, degenerative  and neoplastic 
pathologies  are prevalent.  Thyroid  lesions may  present in the form of  
diffuse enlargement or solitary nodules  or multiple nodules. 
Among  the various thyroid  nodular lesions, incidence of malignancy  is 
relatively low . Hence  diagnostic modalities that have  better ability to 
differentiate  benign from  malignant lesions and  differentiate  between         
non  neoplastic and  neoplastic lesions are of prime importance ,based on 
which further treatment can be decided . 
For more than  a century, the surgeon has been dependant on the 
histopathologist for providing a definitive diagnosis and deciding further 
therapy. As the procedure was complex  and the cost factor  was high, it 
lead to the   utilisation of  exfoliated cells to serve as a screening and 
predictive tool. Later pioneer cytologists  started employing needles into 
tissues to obtain rapid diagnosis. Due to the ever increasing demand for a 
minimally invasive, relatively painless, cheap and rapid diagnostic 
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modality,fine needle aspiration cytology began to flourish and grow 
enormously. Its clinical value is not only  limited to neoplastic 
conditions but also  in establishing  the diagnosis of inflammatory, 
infectious and degenerative conditions for  which samples can be used 
for biological and biochemical analysis.Thus, Fine needle aspiration 
cytology of the thyroid became  established as the first line diagnostic 
test for the evaluation of various thyroid disorders. 
 In clinical practice, FNAC  is  mainly used in  differentiating  malignant 
thyroid  nodules  from  benign nodules as the later can be followed up 
clinically.  Fine  needle  aspiration  cytology involves  the aspiration  of  
cellular  material from the target masses by using   high suction pressure 
with the help of needle and syringe. However, FNA has a disadvantage 
of inadequate and bloody samples as thyroid is a highly vascular organ.  
A  modified sampling technique called fine needle non-aspiration 
cytology (FNNAC) , pioneered in France  by Brifford et al in the 1980s  
has come  into clinical use in recent times.In  FNNAC , active  aspiration  
by  syringe  is  replaced   by the principle of capillary suction of fluid or 
semi fluid material into a thin channel (fine needle)thereby overcoming 
the problems of inadequate and bloody samples . Relative to FNAC 
,FNNAC   is technically  less painful, less traumatic and patient-friendly 
and the smears obtained by FNNAC are of “text book” quality. Studies 
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in the past involving FNAC and FNNAC have been done mainly by 
pathologists. However, in resource limited settings of rural India with the 
non availability of pathologist, the  role of surgeon becomes important. 
Hence,we tried to compare the efficacy of  FNAC with FNNAC  during 
the evaluation of  thyroid lesions , sampling being performed by single 
surgeon. 
Whereas superficial lesions of thyroid are readily accessible with blind 
FNAC technique,deeply seated lesionsare relatively difficult to be  
sampled adequately  for accurate diagnosis for which  imaging 
techniques like ultrasound comes into play.Hence in our tertiary care 
centre set up, we tried to analyse the efficacy of  USG guided FNAC. 
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AIM OF THE STUDY 
 
1. To evaluate the efficacy of fine-needle non-aspiration 
cytology(FNNAC) with that of fine-needle aspiration 
cytology(FNAC) of thyroid lesions as regards to cellular and 
hemorrhagic yield 
 
2. To evaluate the efficacy of fine-needle non-aspiration 
cytology(FNNAC) with  that  of  USG guided FNAC in thyroid 
lesions as regards to cellular and hemorrhagic yield. 
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REVIEW OF LITERATURE 
The thyroid gland is an unique  endocrine gland. It is the first endocrine 
gland to appear in the foetus. It is the largest amongthe endocrine glands 
,weighing about 20 to 25grams . Its another peculiarity  is its superficial 
location  because of which it is amenable  to direct physical examination. 
SURGICAL ANATOMY OF THE THYROID 
GLAND 
FIGURE -1 ANATOMY OF THYROID GLAND 
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The thyroid gland  is a butterfly shaped endocrine organ, situated in the 
anterior aspect of neck,with two bulky lateral lobes which are  connected  
together by a relatively thin isthmus, which extends from the second to 
the fourth tracheal rings.  The  left lobe is  usually shorter than  the right 
lobe. Another  lobe called  the pyramidal lobe, the vestigial remnant of 
thyroglossal duct  may extend from the isthmus  and   is seen in  
approximately 40 to 55% of cases. 
The gland is enclosed  by a fibrous capsule which is then enveloped by 
the visceral layer of the pre tracheal layer of  deep cervical  fascia.  The 
pretracheal fascia  further   gets  attached  superiorly  to  the oblique line 
of thyroid carlilage and posteriorly to the cricoid cartilage and tracheal 
rings  through  the Berry’s ligament, which is responsible for the 
movement of  thyroid during deglutition. 
 
Thyroid is a richly vascularised organ and there is extensive anastomoses 
between the main thyroid  arteries and branches of the tracheal and 
esophageal arteries 
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FIGURE – 2 ARTERIAL SUPPLY OF THYROID 
 
 
 
 
 
 
 
 
.The  superior thyroid artery which is a direct  branch of the external 
carotid artery andthe inferior thyroid artery which is  a branch of the 
thyrocervical trunk of the first part of the subclavian artery  constitute 
the main  arterial  supply of  the gland.  
The thyroideaima artery arising from the brachiocephalic trunk  may be 
seen in  10% of cases    and it supplies the inferior portion of the 
isthmus. The superior thyroid artery has closerelation with  the external 
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branch of superior laryngeal nerve and inferior thyroid artery with  the 
recurrent laryngeal nerve. 
 
FIGURE – 3 VENOUS DRAINAGE OF THYROID GLAND 
 
 
 
 
 
 
 
The superior and middle thyroid veins which  drain  into the internal 
jugular and the  inferior thyroid vein  which  drains  into the 
brachiocephalic vein constitute the venous drainage of the thyroid gland. 
 
 
FIGURE - 4 LYMPHATIC DRAINAGE OF THYROID GLAND 
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The rich lymphatic network  of  thyroid  drains  into central compartment 
level VI nodes_ the Delphian nodes(prelaryngeal), pretrachealand 
paratracheal lymph nodes which inturn drains  into the level II,III,IV,V  
deep cervical nodes and level VII mediastinal nodes. 
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EMBRYOLOGY 
 
           FIGURE – 5   EMBRYOLOGY OF THYROID GLAND 
 
 
 
 
 
 
 
 
The thyroid  anlage  develops in the embryo as a midline structure from 
the median bud in the  floor  of  the pharynx  between the tuberculum  
impar and the cupola . The gland is mainly endodermal in  origin.  It 
descends  down the neck, in front of the hyoid bone and thyroid cartilage  
during which it  remains connected to the tongue at the foramen caecum 
by the thyroglossal duct. The duct usually  closes at  the  fifth  week, the  
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failure  of which results in the formation of  thyroglossal cyst.  Ectopic 
thyroid results from arrest in the  descent of the gland  whereas complete 
failure of descent  results in  lingual thyroid. By the seventh week, the 
thyroid reaches its normal position below the cricoid cartilage. Follicles 
appear and thyroid begins to secrete hormones by the twelfth week.  
The parafollicular C cells derived from neural crest  develops from the 
ultimo bronchial body,which in turn is  derived from the fourth and fifth 
pharyngeal pouch, and becomes incorporated into the lateral portion of 
the thyroid and secretes calcitonin. Sometimes , the ultimobronchial 
body  canpersist as a small nodule called the tubercle of Zuckerkandl. 
Failure of  fusion of the lateral anlage with  ultimobranchial body results 
in the formation of  lateral aberrant thyroid. 
 
HISTOLOGY 
The thyroid gland  is enclosed by a thin fibrous capsule. From this 
capsule, numerous trabeculae  of various thickness invades  the thyroid 
parenchyma and divides it  into lobules. Each lobule is supplied by a 
single arteriole and forms the functioning unit  and consists of 
approximately 24-40 individual follicles. Each follicle is lined by 
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basement membrane and a single layer  of  cuboidal  epithelial cells  and 
is filled with a structure less colloid in the central lumen . The follicular 
cells secrete and store their products in the  colloid which is composed of 
thyroglobulin.  In between the follicles, clusters of pale epithelial cells 
called the parafollicular cells or C-cells are seen. 
 
 
 
 
 
 
 
 
 
 FIGURE – 6 HISTOLOGY OF THYROID GLAND 
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BIOCHEMISTRY 
The basic functional unit of the thyroid is the thyroid follicular cells 
which  synthesise thyroid hormone in four stages which include 
i. Iodide trapping – Active ATP dependent  transport of iodide into the  
follicular cells from the blood  
ii. Organification –the enzyme thyroid peroxidase oxidises the iodide  
which is  then combined with tyrosine to form the inactive iodotyrosines 
– 3 Monoiodotyrosine and 3-5-Diiodotyrosine. These iodotyrosines are 
incorporated into thyroglobulin and stored as colloid in the follicular 
lumen. 
 iii. Coupling - the iodotyrosines are then coupled to form 
T3(triiodothyronine)  and T4( thyroxine) . 
 iv. Release – when hormones are required, colloid is taken up by the 
thyroid  follicular  cell by endocytosis resulting in the  formation of  
endosomes. The thyroglobulin is then hydrolysed to liberate T4, T3, 
Mono and diiodotyrosines. Iodine dehalogenase deiodinates the 
monoand diiodotyrosinesand the released iodide is reused. The active 
hormones thus formed  are secreted into the blood. 
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PHYSIOLOGY 
Most of T3 and T4 in circulation are bound to serum proteins: albumin, 
thyroxine binding globulin(TBG) and thyroxine binding 
prealbumin(TBPA). Metabolically active hormones are  the unbound 
free T4 and T3 which constitutes 0.03 and 0.3 percent of the total 
circulating hormones respectively.  T3 is more potent than T4 and these 
hormones act predominantly via a nuclear thyroid receptor. T4 is 
relatively inactive in the periphery due to its low affinity to the receptor . 
T3 can be produced in periphery from conversion of T4. T3 acts faster 
within a few hours whereas T4 action is slower(4 to 14 days). Thyroid 
hormone synthesis and release  is largely regulated by TSH secreted by 
the anterior pituitary. TSH acts by  binding  to TSH receptor on the 
follicular cell resulting in increased thyroid hormone synthesis via 
cAMP. TRH acts as a  positive stimulus to the production of TSH. TRH 
produced in the paraventricular nucleus of the hypothalamus passes 
through the median eminence to the anterior pituitary via the 
hypophyseal portal system. T3 has a negative feedback on both the 
anterior pituitary and the hypothalamus. The parafollicular cells secrete 
calcitonin which is a sensitive tumour  marker for medullary thyroid 
carcinoma. 
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      FIGURE – 7 PHYSIOLOGY OF THYROID GLAND 
 
 
 
 
 
PATHOGENESIS OF GOITRE 
Simple  goitre results from increased stimulation of thyroid gland by 
TSH, leading to follicular cell hyperplasia and hypertrophy  which may 
be due to 
 1. Increased demand for hormones in physiological states like 
pregnancy and puberty  
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2. Iodine deficiency 
3. Dyshormonogenesis-Enzyme deficiencies resulting in impaired 
hormone synthesis and transport 
4.Goitrogens- Dietary substances – calcium, fluorides, cabbage, 
thiocyanates in cassava. 
5. Destruction of gland by auto antibodies.  
6. Stimulation of TSH receptor by auto antibodies as in Graves disease-
toxic goitre. 
Nearly all long standing simple goitres become transformed into multi 
nodular goitres. Normal thyroid cells are heterogenous with respect to 
iodinating capacity, peroxidase content, endocytic response to TSH and 
ability to replicate. With fluctuating TSH stimulation , there is a mixed 
pattern with areas of active lobules and areas of inactive lobules.  The 
development of nodules indicates the generation of new heterogeneous 
follicles derived from genetically distinct cells and cell clusters in the 
normal gland. Active lobules continue to grow  until    haemorrhage 
occurs causing  caseous necrosis, scarring and calcifications. Necrotic 
lobules coalesce to form nodules which may contain colloid or inactive 
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follicles.Thus in MNG, most nodules are inactive and active follicles are 
seen only in internodular tissue. 
 
CYTOPATHOLOGY 
Structures that can be normally seen in a  smear are 
 1. Follicular epithelial cells 
 2. Colloid  
3. C-Cells . 
Cartilage, Tracheal epithelium and skeletal muscle may also be seen. 
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HISTORY OF FINE NEEDLE  CYTOLOGY: 
     During Medieval times, AbulCasim (1013 – 1107AD),an Arabian 
physician described a technique  of needle puncture of thyroid to 
diagnose different types of goitre.  
  The technique of Needle aspiration biopsy was first recorded by Kun in 
1847. In 1853, Pravazused  a metallic syringe for  the treatment of 
aneurysms. Leyden used trans thoracic needle aspiration to identify  
organisms from pneumonia patients. In 1884, Kronigdiagnosed lung 
cancer by aspirating tissue through a transthoracically inserted cannula. 
In 1904, Greig and Gray did   lymph node aspiration  to isolate causative 
agents of trypanosomiasis . During this aspiration he observed  that the 
cells aspirated from lymph nodes might help in diagnosis. 
In the late 1920s and 1930s, there was  flowering of interest in the papers 
of Dudgeon and Patrick from England who studied cytologic scrap 
preparations from the excised tissues and  proposed needling of tumours 
as a means of rapid diagnosis. Guthrie in 1921 successfully used needle 
aspiration for the  diagnosis   of syphilis, tuberculosis, lymphomas and 
metastatic carcinoma.  During the same period (late 1920s), 
Papanicaloupresented his paper “new cancer diagnosis”, later known as 
pap smear,thusmaking   a  great contribution to the field of exfoliative 
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cytopathology. Pap smear was used  both as screening and diagnostic 
test for cervical cancer.  
HISTORY OF FINE NEEDLE CYTOLOGY OF 
THYROID: 
In 1930, Martin , Stewart and Ellis from the  Memorial Sloan - Kettering 
Hospital of  the United States described the diagnosis of Thyroid nodules 
by needle aspiration  biopsy . They used a thicker needle (18 gauge) for 
aspiration. But this technique did not gain wide acceptance during their 
times  because of fear of malignant implant along the needle tract . 
 In 1960s, the Europeans particularly Scandinavians reintroduced a 
special aspiration biopsy for diagnosing thyroid lesions where they  used 
a finer needle ie, 22 – 25 gauge for aspiration. The FNAC technique 
which was described by Lowhagen et al from Karolinska Hospital  is 
generally adopted now. 
 In 1977, Marvin et al of France  emphasized the importance of   FNAC 
in    pre-operative diagnosis of thyroid nodules. 
 In India, the first major study  in FNAC  was  done by Rao SK et al , 
where  he evaluated  341 cases of solitary thyroid nodules over a period 
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of 10 years from 1957 to 1966. However FNAC became   widely  
accepted  in North America and India after 5 decades in the  1980s. 
 Since 1981 , a  modified technique of FNC termed as Fine Needle Non 
Aspiration Cytology( FNNAC )was  introduced in France by Zajdela et 
al. The same procedure was called as “cyto puncture ” by Brifford et al  
in 1982. 
FNAC THYROID-LITERATURE: 
    Studies by   Smeds et al  shows  that in the  evaluation of nodular 
thyroid lesions , aspiration cytology is a safe and hitherto the best 
diagnostic tool.  While  comparing FNAC  with imaging procedures, 
including  those imaging  for  functional activity, the combined 
sensitivity and specificity rates of aspiration cytology comes closer to the 
ideal discriminatory situation. History , clinical examination and  fine 
needle aspiration cytology in combination  gives  the best guidance for  
optimal selection of patient for therapeutic and diagnostic surgery. 
 Agrawal studied  the diagnostic accuracy of FNAC in the evaluation of  
thyroid nodules in 100 consecutive cases who subsequently underwent 
thyroidectomy  between the years 1989 – 1991. FNAC as a diagnostic 
test for thyroid nodules gave  90.9% sensitivity , specificity of 95.9% , 
false positivity of 2%, false negativity of 4% and  positive and negative 
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predictive values of 86.7% and 92.2% respectively. An accurate  
classification of the  type of carcinoma  was feasible  only in 69%  of 
patients. FNAC is the first line investigation in most non – toxic nodular 
goitres and often the only procedure  that was necessary to obtain a 
correct diagnosis.  
 Ng et al analysed  the cost effectiveness of FNAC as a selection criteria 
for surgery in solitary nodules  in comparison to scintigraphy and 
ultrasonography. Age above 50 years , clinical suspicion and  FNAC in 
combination detected all malignancies and resulted in fewer patients 
undergoing  surgery. Hence they recommended FNAC as a diagnostic 
modality for routine use. 
Lowhagen   and Williams assessed  the role of fine needle cytology in 
the management of thyroid diseases. With  the combined use  of 
aspiration cytology and scinti scans, it is possible to differentiate 
between  non neoplastic and neoplastic follicular proliferation. In cases 
where cytological study is unable togive  a specific or conclusive 
diagnosis, broad disease categories such as inflammatory or neoplastic 
states can be recognized. In post therapy follow up, FNAC allows rapid 
detection of recurrence. 
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Alka et al studied the role  of FNAC in lymphocytic thyroiditis  and 
concluded that FNAC remains the gold standard in comparison to 
ultrasonography and radio nuclide parameters. However the grades of 
thyroiditis does not correlate with the above parameters.  
CURRENT USE AND ADVANTAGES OF FNAC: 
Therefore,Fine Needle Aspiration Cytology  has now become the initial   
investigation of choice in  patients with  thyroid swellings.  It is simple, 
accurate, cost effective, safe and quick to perform in outpatient 
department with high degree of sensitivity and specificity.  It has got 
excellent patient acceptance. 
The main indications for Fine Needle Aspiration Cytology are 
 1.In the diagnosis of diffuse non – toxic goitre by  distinguishing  
colloid goitre from  autoimmune thyroiditis. 
 2. In solitary nodular lesions and in recurrent goitre by  distinguishing 
between malignant and benign lesions  thereby avoiding unnecessary 
surgery for a benign lesion.  
 3. In confirming clinically obvious malignancy thereby in   planning the 
type of surgery 
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 4. To obtain material for special laboratory investigations that are  
aimed at deciding the  prognosis.  
Thyroid conditions that can be diagnosed with FNAC are colloid 
nodules,thyroiditis,medullary carcinoma, papillary carcinoma, anaplastic 
carcinoma and lymphoma. 
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THYROID LESIONS 
 NON NEOPLASTIC LESIONSNEOPLASTIC LESIONS 
1. Infectious Thyroiditis1.Benign 
 - Acute Thyroiditis                                            - Follicular adenoma 
- Chronic Thyroiditis                                         - Hurthlecell Adenoma 
2.Hashimato Thyroiditis2. Malignant lesions 
3.Subacute Thyroiditis  - Papillary Carcinoma 
4.Grave’s Disease           - Medullary Carcinoma  
5.Goitre- Follicular Carcinoma 
 - Diffuse non toxicgoiter             - Anaplastic Carcinoma  
- Multi Nodular goiter 
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CYTOLOGICAL  APPEARANCE OF VARIOUS 
THYROID LESIONS: 
SUBACUTE GRANULOMATOUS THYROIDITIS( DE QUERVAIN`S 
THYROIDITIS) 
• Large multinucleate giant cell with numerous nuclei, 
phagocytosed colloid       
•  Epithelioid cells 
• Degenerating follicular cells 
• Inflammatory cells, macrophages and lymphocytes  
• A dirty background of debris and colloid. 
 
HASHIMOTO THYROIDITIS. (HASHIMOTO’S DISEASE, STRUMA 
LYMPHOMATOSA) 
• Oxyphilic transformation of epithelial cells (askanazy cells)  
• Moderate number of lymphocytes and plasma cells  
•  Scanty or no colloid 
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GRAVES’ DISEASE - (DIFFUSE TOXIC GOITER) 
• Blood stained smear with scanty colloid  
•  Moderate amounts of thyroid follicular epithelial cells  
• Cells have abundant vacuolated pale cytoplasm with mild nuclear 
enlargement and showing moderate anisokaryosis.  
•  Fire flares/colloid suds/marginal vacuoles 
 
FIGURE – 8 GRAVE’S DISEASE 
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DIFFUSE NONTOXIC GOITER (SIMPLE GOITER) 
• Abundant colloid of varying thickness or excessive thick colloid 
with normal Cytological appearance of follicular cells. 
                 FIGURE – 9 COLLOID GOITRE 
 
 
 
 
 
 
 
MULTINODULAR GOITER 
• Abundant thin and thick colloid.  
•  Small to moderate number of follicular epithelial cells in 
monolayered sheets, poorly cohesive groups and single cells.  
•  Both Involutional and hyperplastic follicular epithelial cells often 
some Oxyphilic cells.  
• Fragile cytoplasm.  
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• Variable number of histiocytes.  
•  Degenerative changes:oldblood,debris. 
 
FOLLICULAR ADENOMA 
• Cellular often bloody smear 
•  Many equal sized epithelial cell clusters scattered 
throughout the smear.  
•  Syncytial aggregates, nuclear crowding and overlapping.  
• Micro follicles.  
•  Scanty or no colloid. 
 
FIGURE 10 – FOLLICULAR NEOPLASM 
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PAPILLARY CARCINOMA 
• Cellular smears  
•  Syncytial aggregates and sheets of cells with a distinct anatomical 
border.  
•  Papillary tissue fragments with or without a fibrovascular core  
• Enlarged ovoid strikingly pale nuclei, finely granular powdery 
chromatin 
•  Multiple distinct nucleoli , intranuclear cytoplasmic inclusions 
and nuclear grooves  
•  Dense cytoplasm with distinct cell border.  
 
FIGURE 11 – PAPILLARY CARCINOMA THYROID 
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• Scanty viscous and stringy colloid(chewing gum colloid)  
• Squamoid or histiocyte-like metaplastic epithelial cells  
• Psammoma bodies  
• Macrophages and debris 
 
 
ANAPLASTIC (UNDIFFERENTIATED) CARCINOMA 
• Highly cellular with bizarre large malignant cells showing 
epithelial or spindle sarcomatoid type.  
•  Prominent nuclear pleomorphism,multinucleation and mitotic 
figures 
•  Background shows necrotic cell fragments and debris 
 
                     FIGURE – 12 ANAPLASTIC CARCINOMA 
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MEDULLARY CARCINOMA OF THYROID GLAND 
• Cellular smears with dispersed cells, some clustering may be seen 
.  
•  Variable cell pattern showing plasmacytoid, spindle and small 
cells  
•  Moderate anisokaryosis, occasional scattered very large nuclei 
with bi and multinucleate forms 
•  Uniform stippled nuclear chromatin  
• Amorphous pink/violet background (amyloid) 
 
FIGURE 13 – MEDULLARY CARCINOMA 
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LIMITATIONS OF FNAC 
Awareness of the limitations of any diagnostic procedure is most 
important and it should be stressed that Fine needle aspiration cytology 
is not a substitute for conventional surgical histopathological 
examination.  
 FNAC  can give indeterminate results as it cannot distinguish follicular 
adenoma which is benign from follicular carcinoma , as this 
differentiation is based not on cytology but  on the  histological criteria 
of capsular and vascular invasion . 
The two fundamental elements required for the success of FNAC are 
proper representation of the sample and high quality of smear 
preparations. Risk of unsatisfactory aspirates is more common with 
cystic and partly cystic swellings leading to false negativity. Another 
obstacle in proper cytological interpretation is  an unsatisfactory 
specimen mixed with blood. 
Lowhagen T et al (1979) commented that even in the hands of 
experienced cytopathologist ,about  5-10% of malignancies  cannot  be 
diagnosed by FNAC. The greatest risk of a false negative diagnosis 
occurs with  cystic neoplasms especially cystic papillary carcinoma. 
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Over 40% of cystic neoplasms may be missed by Fine Needle Aspiration 
Cytology. 
In  a six year  study of clinically isolated thyroid swelling,Cusick 
observed  that 148 of 395 swellings were cystic. When  106 (72%) out of  
the 148  patients  with cystic swelling were operated upon, 47% of cystic 
swellings were neoplastic , of which  14% were malignant. Only 12 
cystic lesions were permanently abolished by aspiration and FNAC was 
inaccurate in predicting neoplasia. The incidence  malignancy in cystic 
lesions is higher than generally accepted and most cysts that could not be  
abolished by aspiration should be removed. 
La Rosa et al (1991) observed  a  high false negative rate of 6.4% for 
cystic nodules where as it was only 1.4% for solid nodules. False 
negative diagnoses can also arise from inadequate samples, improper 
sampling technique, dual pathology (example a dominant benign nodule 
may obscure a smaller or more diffusely growing carcinoma) and errors 
in interpretation. 
Layfield et al evaluated the usefulness  of clinical features for selecting 
patients with thyroid lesions who are  suitable for diagnosis by FNAC. 
They found that the only clinical feature that was of statistical value in 
the distinction of benign from malignant nodule is the  presence of 
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lymphadenopathy. Moreover once an aspiration diagnosis of follicular 
neoplasm had been made, no clinical, radiological or laboratory test 
helped in the distinction of follicular adenoma from follicular carcinoma. 
Nari et al  have found  that identification of various variants of papillary 
carcinoma is faesible, though difficulty has been  encountered in 
correctly categorising the follicular variant which is mistaken as 
follicular neoplasm. 
Procedural complications of  thyroid FNC include hematoma, transient 
laryngeal nerve palsy, puncture of trachea causing coughing spasms, 
organisation of hematoma and necrosis which may  mimic a sarcoma or 
angiomatous  tumor. Damage to the capsule by needling may resemble  
capsular invasion. 
Another issue is  that FNC may cause changes in the tissue like 
infarction, pseudo capsular invasion, pseudo malignant changes, and 
reparative reactions which may render subsequent interpretation 
difficult. So the FNC technique should always be done carefully and 
gently to minimize tissue damage.  
The possibility of dissemination of  cancer cells along the needle tract 
initially  caused a great deal of concern, but the review of literature on 
the reported cases of tumor implantation along the needle tract by 
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Roussel et al in 1989 and Power et al in 1996, proved that the risk of 
needle tract seeding is extremely low inwhen truly a fine needle(22-25 
gauge) is used. Multiple passes , larger needles and absence of normal 
parenchyma covering the lesion are factors which  increase the risk. 
FINE NEEDLE NON-ASPIRATION CYTOLOGY 
OF THYROID: 
Fine  needle  aspiration  cytology involves   aspiration  of  cellular  
material from  target masses by using   high suction pressure with the 
help of needle and syringe. However, FNA has a disadvantage of 
inadequate and bloody samples as thyroid is a highly vascular organ. As 
the cytologists faced difficulty in interpreting haemorrhagic samples 
from FNAC of thyroid or  other vascular organs, an alternative sampling  
technique of FNC termed as fine needle non-aspiration cytology 
(FNNAC) or fine needle capillary sampling was  introduced  in France 
by Zajdela et alin 1981. In 1982,the same procedure was called by 
Brifford et al  as “cyto puncture ”. It was first used for breast tumours 
and later for orbital and periorbital tumours. In  FNNAC , active  
aspiration  by  syringe  is   replaced   by  the principle of capillary 
suction  of  fluid or semi fluid material into  a thin  channel (fine needle) 
thereby overcoming the problems of inadequate and bloody samples . 
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Relative to FNAC  , FNNAC   is technically  less painful, less traumatic 
and patient-friendly and the smears obtained by FNNAC are of “text 
book” quality. 
Santos and Leiman et al, in 1988 were the first to compare  FNAC wity 
FNNAC smear in thyroid nodules. They observed that the number of 
unsuitable specimens was not different with both the techniques. Based 
on certain criteria,they graded the specimens into 
Unsuitable – If the smears showed predominantly  blood or if cellular 
material was absent. 
Diagnostically adequate - If the smears were adequate enough to render 
the diagnosis, but the cellularity is suboptimal and if there was 
degenerative changes or specimen entrapment in clots.  
Diagnostically superior - If the cells or cell groups are concentrated , 
well preserved , unobscured by background blood and excellently 
displayed with retention of  architectural structures such as follicles, 
papillae and flat sheets. 
Sharon Mair and Fiona Dunbar et al in 1989 did their comparative study 
of FNAC and FNNAC and the smears were scored on the based five 
objective parameters_ amount of cellular material , retention of 
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architecture, degree of trauma, degree of cellular degeneration and 
background blood or clot . 
The smears were then classified as  
1. Diagnostically Unsuitable -- score 0-2. 
 2. Diagnostically Adequate -- score 3- 6.  
3. Diagnostically superior – score 7-10.  
This study concluded though  there was no statistical difference between  
the efficacy of FNAC and FNNAC, FNNAC smears were diagnostically 
superior and of text book quality and it allows for greater ease of 
sampling and a more sensitive probing of the mass to be sampled. FNAC 
was diagnostic for fibrous  and cystic lesions and suggested that the 
technique of fine needle sampling employed for cytodiagnosis could be 
left to the personal preference of the operator. 
 
Rajasekhar A and Sundaram C et al in 1991 observed that efficiency of 
obtaining adequate material for both the techniques was 80%  and 
FNNAC was more cost effective and relatively  less painful .  The  
diagnostic accuracy of FNNAC  correlated well with that of  FNAC and 
histopathology. Sampling of malignant lesions  was more easy. In their 
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study,anatomic site had no influence on the yield. Most of the negative 
cases were small swellings, less than 1.5 cm in diameter. 
Dey P and Ray R et al in 1993 analysed the quality of diagnostic 
material of FNAC and FNNAC using a scoring system based on 
cellularity and amount of blood in the smear . They observed  that total 
score of FNNAC was significantly higher than FNAC. The FNNAC 
procedure was less traumatic and equally cost effective and can be safely 
undertaken in liver, orbital and thyroid lesions. However, this procedure 
could not be advocated in cystic, bony and fibrous lesions. 
Kumarasingh M , Sheiffdeen AH et al in 1995  found in their 
comparative study that FNNAC was superior to FNAC in thyroid  
whereas  FNAC was superior to FNNAC in benign lesions of breast .  
 
Braun H, Walch C, Beham et al in 1997 observed in their comparative 
study that FNNAC offered several advantages. By avoiding  aspiration, 
trauma to cells and tissues was reduced. Less blood in the samples 
resulted in better quality of the cytological smear. These circumstances 
made it easier for the pathologist to comment accurately on the 
cytological findings. The handling of the needle was practised with a 
wrist movement and not from the shoulder joint as in aspiration method 
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using the Cameco syringe holder. This allowed for a more sensitive 
puncture technique touching the lesion with the finger tips during 
sampling. The puncture resulted in  less pain than the aspiration 
technique.  
Amrita Ghosh , Rajiv kumarMisra et al in 2000 observed in 
theirbcomparative study that in  lymphnode, thyroid and liver lesions 
contamination with blood was more in  aspiration smears than FNNAC 
smears and values were statistically significant. Statistically significant 
better maintenance of architecture was observed  for thyroid lesions 
sampled by  FNNAC technique. Better average scores were observed by 
FNNAC technique for lymphnode and thyroid . On categorizing  the 
smears obtained by FNAC & FNNAC on the basis of scores according to 
predetermined criteria, FNAC yielded  greater number of diagnostically 
adequate specimens  but  more  number of diagnostically superior 
specimens were  obtained by FNNAC technique and  the difference was 
found to be statistically significant. However the number of inadequate 
smears was also more by FNNAC technique than by FNAC 
technique.They observed that both the techniques have their own 
advantages and disadvantages. Therefore they  concluded that by 
combining both the techniques better diagnostic accuracy can be 
achieved. 
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Meherbano M Kamal , DilipArjuna et al  in 2002  observed in their  
comparative study for both the techniques in thyroid lesions that  a 
statistically significant difference in favour of FNNAC was observed for 
the criteria of  amount of cellular material. For the rest of the criteria 
namely, background blood or clot, degree of cellular trauma ,degree of 
cellular degeneration and retention of architecture—FNNAC gained a 
higher average score but was not statistically significant--i.e., smears 
prepared from FNNAC showed  cellular material that was more 
concentrated, less damaged and less likely to be obscured by blood. They 
concluded that although FNNAC sampling was diagnostic in a greater 
number of cases than FNAC sampling,  a clear superiority of FNNAC 
over FNAC is not proved . They also suggested that  until  further  
experience proves  clear sampling superiority of FNNAC alone,instead 
of  performing only FNNAC in diffuse or nodular thyroid lesions, 
incorporating FNAC into the second puncture , will definitely improve 
the quality and quantity of material at the patient's first visit. 
 C V Raghuveer I Leeka et al  in 2002 found  in their comparative study 
that FNNAC was superior in quality and diagnostic accuracy than FNAC 
in thyroid lesions. FNNAC seemed to be better for diagnosing malignant 
lesions while FNACappeared better for diagnosing benign ones. FNNAC 
technique was  more patient friendly and gave "text book" quality smears 
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while FNAC smears gave quantitatively more adequate material. 
Therefore both the techniques would be complementary to each other. 
ShahramHadadiNizhad, BagherLarijani et al  in 2003 designed  a 
comparative study in thyroid lesions . The specimens were scored (0, 1, 
or 2) on the basis of background blood or clot, number of obtained cells, 
preserved architecture of papillae and follicles, and cellular 
degeneration. They concluded that FNNA is not superior to FNA in the 
cytopathologic studies of thyroid nodules. 
Ceresine G, Corcione L et al in 2004  observed  that inadequate samples 
may occur in thyroid FNAC leading to a repetition of the procedure with 
the consequenceof patients' discomfort and poor compliance. They 
concluded that the combination of US guidance, capillary collection with 
no-aspiration technique, and onsite review of slides, characterizes an 
advantageous method for thyroid nodule fineneedle biopsy. 
Yasub E Al Khattab et al in 2004 observed that each sampling technique 
has its own advantages and disadvantages and to choose one of them was 
based on  the operator’s personal preference . They suggested that if only 
one needle pass was to be performed or to minimize the patient 
discomfort or to reduce the screening time, FNAC probably has  greater 
chance of producing a diagnosis than FNNAC.  
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S A Ali Rizvi , M Hussain et al in 2005 observed that the non-aspiration 
technique yielded more diagnostically adequate specimens in thyroid 
lesions, as compared with FNAC. The number of unsuitable smears was 
also greater in aspiration samples, as compared with the non-aspiration 
technique. The non-aspiration technique was simple, easy to perform and 
produced better results in the form of a better quality of the cellularity 
and less field obscurity by blood in both neoplastic and non-neoplastic 
lesions of the thyroid. This technique should be used alone or in tandem 
with FNAC for better diagnostic yield. 
David D Pother , AA Narula et al in 2006 did a literature search and a 
systematic review was undertaken, looking for prospective trials to 
compare the two methods . Criteria for inclusion of studies into meta-
analysis were: (i) randomised controlled trials or cross-over trials; (ii) 
blinded randomisation allocation; and (iii) blinded cytopathologist. The 
outcome measures were: (i) adequacy of sample for diagnosis; and (ii) 
reliability of diagnosis made. 
 The following papers fulfilled the inclusion criteria: Haddad-Nezhad et 
al., Ghosh et al. , Mair et al., Raghuveer et al and Santos and Leiman. All 
used the same method of double sampling each thyroid lesion by FNAC 
and FNNAC. The first four studies all used the same technique for 
assessing the aspirate. This was achieved by the use of a point-scoring 
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system devised by Mair et al. Santos and Leiman used a different system 
where each sample was categorised into diagnostic superior, diagnostic 
or unsuitable. This study was not included in the meta-analysis. 
Although there have been five high-quality trials on the subject, there 
was no evidence from a meta-analysis that one method of collection of 
cytological material was better than another in the investigation of 
thyroid lesions. Taking into consideration all the data entered into the 
meta-analysis, there seems to be some evidence favouring FNNAC. 
 
Mitchell E Tubulin, Joseph A Martin et al  in 2007 did a study to 
compare USG guided FNAC and FNNAC in thyroid nodules and 
observed that the results were comparable with equivalent diagnostic 
yields. The technical ease of capillary sampling may prompt adoption of 
FNNAC at high volume endocrine and radiology practices. 
 Federico Ronietelli , Enrico Distasio et al , in 2009 did a similar 
comparative study like Mitchell E Tubulin et al ., and found that there 
was statistical difference between two techniques only on the number of 
inadequate results. However they concluded that  being  minimally 
invasive procedure, better quality of smears  and reduced inadequate 
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results , FNNAC should be preferred for FNAC in cytological evaluation 
of thyroid nodules. 
In a study conducted by Nisha P Malik et al in 2009 , FNAC and 
FNNAC smears from thyroid nodules were assessed for  
cellularity,background blood or clot and retention of architecture ,based 
on which it was categorised into unsuitable, adequate and diagnostically 
superior for cytological evaluation . They observed that FNAC yielded 
more cellular material  and had a higher score for background blood. 
FNAC yielded more diagnostically superior samples whereas FNNAC 
yielded more diagnostically adequate samples. Both the techniques 
yielded equal number diagnostically unsuitable smears. They concluded 
that technique of fine needle sampling to be left to the operators’ 
personal preference. 
A similar study conducted by Anil Kumar Maurya et al in 2007showed 
that more number of diagnostically superior samples were obtained with 
FNNAC whereas FNAC yielded more number of diagnostically 
adequate smears .The number of unsuitable smears was greater with 
FNNAC. They concluded that both the techniques have their own merits 
and demerits and by combining both the techniques ,diagnostic accuracy 
can be improved. 
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ULTRASOUND GUIDED FNAC: 
 One of the major limitations of FNAC thyroid is a high inadequacy rate 
which ranges from 6.4% to 32.4% in various studies. Although the rate 
of inadequate aspirate can be reduced by repeated aspiration and 
experience, it increases the number of patient visits to the clinic , the 
consequences of which are decreased  efficacy and cost effectiveness. It 
also adds to the anxiety and apprehension of the patient by decreasing 
the confidence in the surgeon and pathologist. This problem can be 
overcome by using ultrasound guided FNAC which not only decreases 
the inadequacy rate but also helps in the accurate selection of patients for 
surgery ,thereby ,avoiding unnecessary diagnostic thyroidectomies. It 
helps in careful selection of biopsy site by avoiding cystic areas and 
areas of coarse calcification. Thus it helps in diagnosing 
microcarcinomas,cystic carcinomas,cancer associated with benign 
nodules like Hashimoto”s thyroiditis or coarse calcification.  
Miskin and walfish PG of England were the first to design a  prospective 
study by combining  ultrasonography with FNAC in cases of hypo 
functioning thyroid nodules to distinguish benign from malignant 
nodules. 
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USG guided FNAC as a diagnostic modality  was first introduced by 
Rizatto et al in 1973. 
Takashima et al showed that accuracy, sensitivity, specificity and 
negative predictive value of USG guided FNAC in diagnosing 
malignancy were not different from that of blind FNAC significantly. 
However , the initial failure rate was significantly higher with blind 
FNAC. 
According to  Hatada  et al, sensitivity, specificity and accuracy was 
better with USG-FNAC especially  when the tumour size is less than 2 
cm. 
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MATERIALS AND METHODS 
PLACE OF STUDY: 
Department of General Surgery, Govt.  Stanley Medical College 
&Hospital,Chennai 
DURATION: 
JAN 2015 TO SEP 2015 
STUDY DESIGN: 
Prospective study 
 
SAMPLE SIZE :75 
INCLUSION CRITERIA: 
Patients with clinically palpable thyroid swelling 
EXCLUSION CRITERIA: 
Patients with         - Coagulopathty or bleeding diathesis  
                              -Age less than 14 years 
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METHODOLOGY: 
 
• Patients attending Out patient and In patient Department of 
General Surgery with clinically palpable thyroid swelling from 
January 2015 to September 2015 are included in this study 
• Patients were randomised into 3 groups_ 25 patients in each group 
• After a thorough clinical examination, all the patients  in group 1 
were  subjected to FNAC  
• Patients  in group 2 were  subjected to FNNAC 
• Patients  in group 3 were  subjected to USG guided FNAC 
•  The details of the technique of Fine needle cytology  were 
explained to the patient and an appropriate consent was  obtained 
from each case before performing the procedure 
• After subjecting patients to FNNAC and FNAC using 23 gauge 
needle,the samples were smeared and air dried and sent to the 
pathologist. 
• Cytological evaluation and reporting was done by pathologist 
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FINE NEEDLE ASPIRATION CYTOLOGY – 
PROCEDURE 
EQUIPMENTS NEEDED:	  
• 23  gauge needle 
• 10 ml Syringe/syringe holder 
• Gloves 
• Cotton 
• Fixative 
• Coplin jars 
• Lidocaine 
• Skin disinfectant 
• Glass slides 
• Glass marking pencil 
• Sterile test tube for collecting any fluid or pus from cystic lesions.	  	  
PATIENT PREPARATION  
• A detailed  explanation was given to the patient regarding  the 
procedure, number of pricks that would be needed  and the 
possible complications of the procedure and a  written consent was 
obtained. 
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• With the patient lying supine on the examination couch, the 
swelling was inspected and then  palpated.  
• The  overlying skin was then  cleansed with alcohol. 
•  A 10 ml plastic syringe attached with a 23 gauge  needle was held 
in the right hand while  the nodule  was firmly grasped with two 
fingers of the left hand.  
• Needle was rapidly inserted through the skin into the nodule.  
• Once the needle tip has reached   the nodule, gentle suction was 
applied while the needle is moved back and forth in the nodule 
vertically. This manoeuvre allows the dislodging of cellular 
material and easy suction into the needle .  
• During the period of 5-10 passes, suction was maintained and as 
soon as fluid or aspirate appears in the hub of the needle, the 
suction was released and the needle was withdrawn . 
• The appearance of fluid suggests that nodule is cystic . The 
suction pressure is maintained to aspirate all the fluid and then 
FNAC was to be done in the residual lesion or mass. Once the 
material is seen in the hub of the needle, the needle is taken out of 
the swelling and detached from the syringe. 
•  5 ml of air was drawn into the syringe and the needle was 
reattached to the syringe and with the level pointing down, drop of 
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aspirated material was forced onto each of the several glass slides. 
It is important that all the slides are labelled and placed in order on 
a nearby table before the aspiration smears are prepared. 
FINE NEEDLE NON ASPIRATION CYTOLOGY – 
PROCEDURE 
• For this technique, patient preparation is similar to that of FNAC .  
• No syringe or suction is necessary for this technique.  
• After identifying the swelling, under   sterile aseptic precautions, 
the hub of the needle is held in a pencil grip fashion in the right 
hand and the needle was gently inserted into the swelling and then 
moved in and out over 5-10 seconds rapidly.  
• Aspirate flows into the needle through capillary action and as soon 
as the aspirate appears in the hub , the needle is withdrawn and 
attached to the syringe with air inside.  
• The material from the needle is  expelled onto the glass slides 
using the plunge. 
•  The procedure is repeated and slides are prepared as that of the 
FNAC.  
• After the procedure is over, firm pressure was applied to the 
aspirated site with cotton.  
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• Once the bleeding has stopped, adhesive bandage is placed on it.  
• The patient is observed for few minutes and if there are no 
problems, he/she is allowed to leave. 
 
PREPARATION OF SMEARS 
• The aspirate contained in the needle was expelled on to a clean 
glass slide using air in a syringe, taking care to avoid splashing. 
•  The smears were prepared by using a second glass slide exerting a 
light pressure to achieve a thin, even spread, in a manner similar to 
that of making blood smears. Too firm pressure produces crush 
artefacts	  . 
• Smears were air dried and  the slides were fixed in 85% of the 
Isopropyl alcohol in Coplin jars and then sent to the pathology 
department for cytological evaluation. 
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USG GUIDED FNAC-PROCEDURE 
• Written informed consent was obtained from the patient 
• Patient was in supine position with neck in extension 
• Ultrasonography was performed by radiologist using a 7.5 MHz 
transducer  
• Sterile gel was used as a coupling agent and no local anaesthesia 
was given 
• Under the guidance of radiologist,23 G needle was introduced 
directly into the lesion through the skin 
• The needle was inserted obliquely along a path parallel to the 
scanning plane ,so that tip and shaft of the needle were visualised 
continuously. 
• When the needle reached the lesion, technique of FNAC was 
followed. 
•    All the needle sampling procedures were made by a single 
operator, bias was thus avoided in all stages of sampling from 
patient examination to slide smear preparation 
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STAINING PROCEDURE 
• the slides were fixed in 85% Isopropyl alcohol for 20 -30 minutes.  
• In  the pathology department,the slides were stained with Harris 
Hematoxylin for 5 to 8 minutes , washed in water, followed by 
differentiation by dipping in 0.5% acid alcohol for 3 to 5 seconds. 
•  After rinsing the slides in water, blueing was done by placing the 
slides in running water for 10 to 20 minutes. Then the slides were 
dipped in 1% aqueous Eosin once. The slides were then washed in 
water.  
• Finally the slides were dried and mounted in D.P.X. 
• The slides were studied and a cytological diagnosis was made  
• All the slides were objectively analysed using a point scoring 
system to enable comparison between FNAC and FNNAC and 
USG guided FNAC  techniques  
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Scoring system developed by Mair et al  to classify quality of 
cytological aspirate 
TABLE -1 
Criterion Qualitative description Point 
score 
Background blood or 
clot 
Large amount; great compromise 
to diagnosis 
0 
 
 
Moderate amount; diagnosis 
possible 
1 
 Minimal diagnosis easy; specimen 
of ‘textbook’ quality 
2 
Amount of cellular 
material 
Minimal to absent; diagnosis not 
possible 
0 
 Sufficient for diagnosis 1 
 Abundant; diagnosis simple 2 
Degree of cellular 
degeneration 
Marked; diagnosis impossible 0 
 Moderate; diagnosis possible 1 
 Minimal; good preservation; 
diagnosis easy 
2 
Degree of cellular 
trauma 
Marked; diagnosis impossible 0 
 Moderate; diagnosis possible 1 
 Minimal; diagnosis obvious 2 
Retention of 
appropriate 
architecture 
 Minimal to absent; non-diagnostic 0 
 Moderate; some preservation of, 
for example, follicles 
1 
 Excellent architectural display 
closely reflecting histology; 
diagnosis obvious 
2 
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On the basis of five criteria tabulated , a cumulative score was obtained 
for each case which was then categorized accordingly to one of the 3 
categories 
1. Unsuitable for cytological diagnosis- (0-2) 
 2. Diagnostically Adequate- (3-6)  
3. Diagnostically superior - (7-10) 
STATISTICAL FORMULA USED TO ANALYSE THE 
RESULTSAll the results were interpreted statistically using Z test or 
student’s ‘t’- test 
                 TABLE -2 
S.No. FORMULA & ABBREVIATIONS 
1 Standard error of difference 
between two proportions 
√ [p1q1/n1+ p2q2/n2] 
2 Z score for standard error of 
difference between two 
proportions 
p1-p2/standard error of difference 
between two proportions 
3 P Probability 
4 P<0.05 statistically significant at 5% 
level 
5 P>0.05 Not statistically significant at 5% 
level 
6 p1 proportion of cases (1st category) 
7 p2 proportion of cases (2nd 
category). 
8 q 1 1-p1 
9 q 2 1-p2 
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OBSERVATION AND RESULTS 
Total number of  cases studied : 75 
Cases subjected to FNAC: 25 
Cases subjected to FNNAC: 25 
Cases subjected to USG guided FNAC: 25 
• Among the 75 cases of thyroid swelling studied, there were 68 
females and 7 males, thus confirming the higher prevalence of 
thyroid diseases among females. 
                                     TABLE -3 
         SEX NO. OF 
CASES 
PERCENTAGE 
Total      75     100% 
       Male      7       9% 
       Female      68       91% 
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FIGURE - 14 
 
FIGURE - 15 
 
Most of the cases were found to be in the age group of 15 to 35 
years. 
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DISTRIBUTION OF THYROID 
DISEASE 
• Out of 75 cases studied,14 cases of nodular colloid goitre,29 cases 
of cystic colloid goitre, 29 cases of autoimmune thyroiditis  and 3 
cases of malignancy were noted. 
TABLE- 4 
Sl. No.                    Diagnosis No. of cases 
   1 Nodular colloid goitre 14(19%) 
2 Cystic colloid goitre 29(39%) 
   3 Autoimmune thyroiditis 29(39%) 
4 Follicular neoplasm 1(1%) 
5 Papillary carcinoma 1(1%) 
6 Medullary carcinoma 1(1%) 
 Total 75(100%) 
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FIGURE - 16	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COMPARISON BETWEN FNAC & FNNAC: 
• The results obtained from  FNAC & FNNAC from thyroid lesion 
and scoring and grading was done accordingly. 
•  Analysis showed that  more number of diagnostically superior 
samples were obtained  from FNNAC technique than that of 
FNAC. 
• Whereas FNAC has more number of diagnostically adequate 
samples than that of FNNAC, diagnostically inadequate samples 
are equal in both FNAC & FNNAC 
 
                                     TABLE – 5 
S.NO GRADING OF SMEARS  FNNAC FNAC 
1 Diagnostically superior 18(72%) 11(44%) 
2 Diagnostically adequate 6(24%) 13(52%) 
3 Diagnostically unsuitable 1(4%) 1(4%) 
4 Total  25 25 
 
 
69 
	  
 
FIGURE – 17 GRADING OF SMEARS IN THYROID 
LESIONS 
 
	  
	  
• Based on comparison of superior quality of smears obtained 
by FNAC & FNNAC , it was found that more number of 
superior quality of smears were produced by FNNAC than 
FNAC and the difference  was found to bestatistically 
significant (p<0.05) 
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TABLE – 6 
COMPARISON OF SUPERIOR QUALITY OF SMEAR 
 
	  	  	  	  	  	  	  	  	  	  	  	  FNNAC	   	  	  FNAC	   Z	  SCORE	   P	  VALUE	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18	   	  	  	  	  11	   	  	  	  	  	  2	   	  	  	  P<0.05	  
 
 For   each parameter ,the score obtained was added and  an average 
score for each parameter  was obtained in FNAC and FNNAC  and 
tabulated. Total average score was then obtained by adding all the scores 
in  FNAC & FNNAC and was found to be 5.8& 6.5 respectively.     
                                    TABLE –   7  
 
 
  
 
      TOTAL AVERAGE SCORE 
  1        FNAC 5.8 
  2   FNNAC 6.3 
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 Based on the average score from each parameters in FNAC & FNNAC 
of thyroid lesions , it was found that FNNAC score was numerically 
higher than FNAC. 
 
TABLE - 8 
 
 
 
 
 
         AVERAGE SCORES OF FNAC & FNNAC 
S.NO Technique Adequacy Architecture Cellular 
degeneration 
Cellular 
trauma 
Background 
of blood 
1 FNAC 1.72 1.08 1.04 1.04 1.08 
2 FNNAC 1.84 1.20 0.96 1.08 1.64 
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FIGURE – 18. AVERAGE   SCORE FOR EACH PARAMETER IN 
FNAC & FNNAC 
 
The diagnostic adequacy was equal in  both FNNAC and  FNAC 
techniques in thyroid lesions. The results of both FNAC & FNNAC for 
diagnostic adequacy were compared, analysed  using Z test and  found to 
be statistically insignificant , P > 0.05. 
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COMPARISON OF FNNAC VS USG GUIDED 
FNAC: 
Out of 50 patients, 25 patients were subjected to FNNAC & 25 patients 
were subjected to USG guided FNAC from thyroid lesions. The smears 
was scored and graded accordingly. Based on the results, it was found 
that superior quality smears were  more in FNNAC technique, but 
diagnostically adequate samples are more in USG guided FNAC than 
FNNAC. 
 
TABLE – 9 
S.NO GRADING OF 
SMEARS 
 FNNAC USG GUIDED 
FNAC 
  1 Diagnostically unsuitable 1(4%)      0(0%) 
  2 Diagnostically adequate      6(24%) 13(52%) 
  3 Diagnostically superior 18(72%) 12(48%) 
  4     Total      25 25 
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FIGURE - 19 GRADING OF SMEARS IN THYROID LESIONS 
 
 
  By comparing superior quality smears obtained by FNNAC and USG 
guided FNAC , it was found that FNNAC technique produced more 
number of superior quality smears than USG guided FNAC and the 
result was found to be statistically significant ( P< 0.05 ) 
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TABLE – 10 
COMPARISON OF SUPERIOR QUALITY SMEARS FROM 
BOTH TECHNIQUES: 
FNNAC USG GUIDED 
FNAC 
Z SCORE P VALUE 
    18      12   1.7321  P < 0.05 
 
By summing up all the scores , the score per case and average score for 
each parameter in each case were obtained and tabulated. The score for 
FNNAC & USG guided FNAC was found to be 6.3 and 5.9 respectively 
TABLE – 11 
                 TOTAL AVERAGE SCORE    
1 FNNAC    6.3 
2 USG guided FNAC 5.9 
 
    The average score between FNNAC &USG GUIDED FNAC for each 
parameters was calculated and the result was found that scores of 
FNNAC was numerically higher than USG guided FNAC technique 
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TABLE – 12 
            AVERAGE SCORES OF FNNAC & USG GUIDED FNAC 
S.NO Technique  Adequacy  Archite
cture  
Cellular 
degeneration 
Cellular 
trauma 
Backgr
ound 
blood 
1 FNNAC 1.84 1.20 0.96 1.08 1.64 
2 USG 
guided 
FNAC 
1.72 1.20 1.0 1.0 1.04 
 
FIGURE - 20    AVERAGE SCORES OF FNNAC & USG GUIDED 
FNAC 
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The diagnostic adequacy of both FNNAC & USG guided FNAC was 
compared . Even though  USG guided FNAC has slightly higher value 
than FNNAC, statistical analysis found it to be statistically insignificant. 
The results were compared and analysed based on Z test and result found 
to be statistically insignificant , (P > 0.05). 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
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Currently  fine needle sampling is a commonly employed technique for 
cytodiagnosis of thyroid lesions . Malignancy in thyroid is less prevalent 
(3 to 5%) compared to benign lesions. Arriving at a correct diagnosis by 
proper utilisation of FNC  can thus help in reducing diagnostic 
thyroidectomies. The  underlying  principle in fine needle aspiration 
cytology (FNAC)  involves  the aspiration of cellular material from 
target masses by  the application of  suction pressure. An alternative fine 
needle sampling technique called fine needle non aspiration cytology 
(FNNAC), developed in France, in which tumour cells are obtained with 
a  thinner needle by using capillary action. In the present study ,fine 
needle non  aspiration  technique is compared to that of  blind FNAC and 
USG guided FNAC  to evaluate their efficacy. 
This study included the samples collected  from 75 patients with thyroid 
swelling, 25 of which were obtained by blind FNAC, 25 by FNNAC and 
another 25 by USG guided FNAC.  
On the basis of five objective parameters which includes cellular 
adequacy, retention of architecture, degree of cellular trauma, degree of 
cellular degeneration and background blood, smears obtained by  FNAC 
& FNNAC   were scored according to a scoring system designed by 
Mairet el in 1989. The number of superior quality smears, total average 
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score , mean score for each parameter and the diagnostic adequacy were  
compared and analysed statistically using Z test or student’s ‘t’ test . 
On considering all the observations and results of each technique in 
thyroid ,it was found that  the number of superior quality smears were  
more from FNNAC technique ( 18 Vs 11) and this difference was found 
to be statistically significant (P<0.05). 
 
                          TABLE - 13 
S.no Technique Average score Diagnostic 
adequacy 
No. of superior 
quality smears 
1 FNNAC 6.3 96% 18(72%) 
2 FNAC 5.8 96% 11(44%) 
3 P value P>0.05 P>0.05 P<0.05 
 
The number of unsuitable smears were equal in both the techniques. On 
analysing the mean score under sub categories like cellular adequacy, 
retention of architecture, degree of cellular trauma and background 
blood, scores obtained by FNNAC were numerically higher than FNAC. 
Particularly the amount of  background blood was  found to be very less 
in FNNAC technique. On analysing the average scores , the average 
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score obtained by FNNAC was more than FNAC (  6.3 Vs 5.8). 
However ,the diagnostic adequacy was found to be the same with both 
techniques. (96%),thus conferring no statistical difference . 
Although this study showed no statistically significant difference 
between FNAC and FNNAC with respect to average scores  and 
diagnostic adequacy, it proved a statistically significant difference in the 
number of superior quality smears for which FNNAC is superior to 
FNAC. Also, this study demonstrated the fact that background blood was 
less with FNNAC than FNAC.  Thus, in  a highly vascularised organ like 
thyroid, FNNAC is preferred over FNAC. 
However, in  cystic lesionsof thyroid like colloid goitre , colloid nodule, 
and cystic degeneration in a nodular colloid goitre, FNAC is the 
procedure of choice. It allows adequate  drainage of  fluid material and it 
is also  therapeutic in cases of simple benign cysts. FNAC yielded 
adequate diagnostic material in those  cases. 
The results obtained in this study of comparison of two techniques of 
FNC  in thyroid swelling is in concordance  with the results of  various 
studies conducted in the past.  
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The observations and the range of scores correlated well with the 
following studies : Mair et al in 1989 , CV Raghuveer I Leeka et al in 
2002 , S Alirizvee M Hussain et al  in 2005 , and Mitchell et al in 2007. 
 
                                          TABLE - 14 
 COMPARISON OF THE NUMBER OF SUPERIOR QUALITY 
SMEARS OBTAINED BY FNNAC & FNAC WITH OTHER 
STUDIES: 
AUTHOR/ YEAR FNNAC FNAC P value 
Ali Rizvee et al in 
2005 
44.7% 45% P < 0.05 
Present study 72% 44% P <0.05 
(statistically 
significant) 
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TABLE - 15 
COMPARISON OF THE DIAGNOSTIC ADEQUACY(%) OF 
FNNAC & FNAC IN THYROID LESIONS WITH OTHER 
STUDIES : 
Diagnostic adequacy FNNAC FNAC P value 
CV Raghuveer et al in 2002    82.4% 77.9% p >0.05 
Mitchell et al  in 2007 87% 89% p>0.05 
Present study 96% 96% p>0.05 
(statistically 
insignificant) 
 
On comparing FNNAC with USG guided FNAC , this study showed that  
the number of superior quality smears were  more from FNNAC 
technique ( 18 Vs 12) and this difference was found to be statistically 
significant (P<0.05). 
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TABLE - 16 
S.no Technique Average 
score 
Diagnostic 
adequacy 
No. of superior 
quality smears 
1 FNNAC 6.3 96% 18(72%) 
2 USG -FNAC 5.9 100% 12(48%) 
3 P value P>0.05 P>0.05 P<0.05 
 
The number of unsuitable smears were none with USG guided FNAC 
favouring its use in cystic lesions of thyroid . On analysing the mean 
score under sub categories like cellular adequacy, retention of 
architecture, degree of cellular trauma and background blood, scores 
obtained by FNNAC were numerically higher than FNAC. Particularly 
the amount of  background blood was  found to be very less in FNNAC 
technique thus contributing to a higher average score. On analysing the 
average scores , the average score obtained by FNNAC was more than 
USG- FNAC (  6.3 Vs 5.9). The diagnostic adequacy was found to be 
better with USG- FNAC(100% Vs 96%)  but with no statistical 
difference . 
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Although this study showed no statistically significant difference 
between USG-FNAC and FNNAC with respect to average scores  and 
diagnostic adequacy, it proved a statistically significant difference in the 
number of superior quality smears for which FNNAC is superior to 
FNAC. Also, this study demonstrated the fact that background blood was 
less with FNNAC than USG-FNAC,thus favouring FNNAC over USG-
FNAC. However it is to be remembered that  in cystic thyroid lesions, 
USG-FNAC is preferred . 
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CONCLUSION 
• For highly vascular organs like thyroid , FNNAC is the preferred 
technique as there is better  material with less admixture of blood. 
The number of superior quality smears without admixture of blood 
is more from FNNAC. FNAC smears although equally  diagnostic, 
mostly produced diagnostically  adequate rather than superior 
quality smears. 
• For the cystic lesions of thyroid , FNAC is the procedure of choice 
as it allows adequate  drainage of fluid material and is also  
therapeutic in some cases, thus yielding  more diagnostic material. 
And the use of ultrasound enhances the diagnostic adequacy of 
FNAC by reducing the number of unsuitable smears obtained  in 
smaller and  cystic lesions. However, the number of superior quality 
smears is significantly higher with FNNAC than USG-FNAC. 
• Hence, the decision to use either FNNAC or FNAC may be decided 
on the basis of site, size and nature of lesion (solid or cystic). 
• In conclusion, each technique has its own merits and demerits. Both 
the techniques can be combined to obtain a high quality material 
and to lower the failure rates and  ultrasound can be utilised 
whenever possible. 
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PROFORMA	  
SL. NO: 
• NAME :     AGE /SEX:  IP NO: 
• ADDRESS WITH CONTACT NUMBER: 
• DATE OF ADMISSION:     
• DATE OF DISCHARGE/ DEATH: 
HISTORY OF PRESENTING ILLNESS: 
H/O swelling in the neck _ Onset 
                       _Duration 
                                         _Rate of growth 
                         _Pain 
H/o dyspnoea/ dysphagia/ hoarseness of voice/ syncope 
H/o loss of weight/ heat intolerance/ excessive sweating/ diarrhoea 
H/o increase in weight/  cold intolerance/ constipation 
H/o bone pain/ hemoptysis/ jaundice 
PAST HISTORY: 
Whether a known case of DM/ hypertension/ asthma/ TB/ epilepsy/ 
cardiac illness 
H/o previous surgeries, if any: 
H/o radiation exposure in childhood if any: 
H/o drug intake,if any: 
 
PERSONAL HISTORY: 
Age of menarche  
Marital status 
95 
	  
Consanguinity 
No.of. Children 
Menstrual cycle: regular / irregular   
Age of menopause: 
FAMILY HISTORY: 
H/o similar complaints in the family members,if any 
ENVIRONMENTAL HISTORY 
H/o similar illness in the neighbourhood. 
 
CLINICAL EXAMINATION: 
General examination: 
Local Examination: Thyroid swelling 
         Neck 
                                 Oral cavity 
Systemic examination: 
CVS 
RS 
CNS 
Abdomen 
 
CLINICAL  DIAGNOSIS: 
 
INVESTIGATIONS: 
CBC: 
RFT: 
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SERUM  CALCIUM: 
HIV: 
HBsAg: 
Anti-HCV: 
Blood Grouping & Typing: 
BT/CT: 
Chest X-Ray: 
ECG: 
THYROID PROFILE: 
FNAC/FNNAC/USG-FNAC: 
USG NECK: 
PRE OP VOCAL CORD  ASSESSMENT:  
 
FINAL DIAGNOSIS: 
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Patient Information Module 
You are being invited to be a subject in this study. 
Before you participate in this study, I am giving you the following 
details about this trial, which includes the aims, methodology, intervention, 
possible side effects, if any and outcomes: 
All patients having thyroid  swelling will be included in this study. A 
detailed clinical history will be taken following a standardized proforma. A 
detailed clinical examination will be made and relevant basic investigations 
will be done at the time of admission.25 patients are subjected to FNAC , 25 
with FNNAC &25 with USG guided FNAC. The results arising from this 
study will be analyzed and used for academic purposes. You will be given 
clear instructions at every step and you are free to ask/ clarify any doubts. 
Your identity will remain confidential. You are free to withdraw from this 
trial at any point of time, without any prior notice &/ or without any medical 
or legal implications.I request you to volunteer for this study. 
Thanking You, 
 
Investigator’s Sign                                    Patient’s Sign 
(Dr.M. SAKTHI BALAN)        (Name:                            ) 
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Informed Consent 
Name:      Age/ Sex:       IP: 
I herewith declare that I have been explained in a language fully 
understood by me regarding the purpose of this study, methodology, 
proposed intervention, plausible side effects, if any and sequelae. 
I have been given an opportunity to discuss my doubts and I have 
received the appropriate explanation. 
I understand that my participation in this study is completely voluntary 
and that I am free to withdraw from this study at anytime without any 
prior notice &/ or without having my medical or legal rights affected. 
I permit the author and the research team full access to all my records at 
any point, even if I have withdrawn from the study. However my identity 
will not be revealed to any third party or publication. 
I herewith permit the author and the research team to use the results and 
conclusions arising from this study for any academic purpose, including 
but not limited to dissertation/ thesis or publication or presentation in any 
level. 
Therefore, in my full conscience, I give consent to be included in the 
study and to undergo any investigation or any intervention therein. 
 
Patient’s Sign  Investigator’s Sign 
 
Dr.M.SAKTHI BALAN) 
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   அரச ஸஸடடனஸலல மரதஸதவகஸ கலஸலரல, சசனஸனன - 600 001.
  பஙஸக சபறபவரலனஸ ஒபஸபமஸ
 ஆரடயஸசஸசலயலனஸ தனலபஸப : னதரடயஸ சரபலயல ஸ ஊசல  லமஸ உறலதலஸ 
மறஸறமஸ உறலயடமலஸ மறஸறமஸ ஸககனஸ #லமஸ எ%தஸதலஸ ஒபஸபனம ஆயஸவ
  ஆரடயஸசஸசல நனடசபறமஸ இடமஸ :    அரச ஸஸடடனஸலல மரதஸதவகஸ
கலஸலரல, 
சசனஸனன - 1.
 பஙஸக சபறபவரலனஸ
 சபயரமஸ #கவரலயமஸ :
நடனஸ,  ...........................................................   இநஸத ஆரடயஸசஸசலயலனஸ
      வலவரஙஸகனள எனத சசடநஸத சமடழலயல ஸ கற அறலநஸத சகடணஸகடனஸ.
     இநஸத ஆரடயஸசஸசலயலனஸ #ழவலவரஙஸகனளயமஸ நடனஸ அறலநஸத சகடணஸகடனஸ.
       இநஸத ஆரடயஸசஸசலயல ஸ நடனஸ பஙஸகசபறமஸ கபடத எனகஸக ஏறஸப%மஸ நனஸனம
   ததனமகனள #ழவதமடக அறலநஸத சகடணஸகடனஸ.
     இநஸத ஆரடயஸசஸசலயலனஸ கபடத எபஸகபடத கவணஸ%மடனடலமஸ நடனஸ
 வல கலகஸசகடளஸளலடமஸ எனஸபதயமஸ,     அதனடலஸ எனகஸக கலனடகஸகமஸ
     மரதஸதவதஸதல ஸ எநஸதவலத மடறஸறகமட படதலபஸகபட இரகஸகடத எனஸறமஸ
அறலகவனஸ.       இநஸத ஆரடயஸசஸசலயல ஸ நடனஸ பஙஸகசபறவதறஸகடக நடனஸ எநஸதவலத
சனஸமடன#மஸ (பணமடககவட,  சபடரளடககவட)  வடஙஸகமடடஸகடனஸ.  இநஸத
 ஆரடயஸசஸசலயலனஸ #டவகனள,     எனஸ அனடயடளஙஸகனள கறலபஸபலடடமலஸ
      மரதஸதவ இதழஸகளல ஸ சவளலயலட எனகஸக எநஸத ஆடஸகசபனனயமஸ இலஸனல.
      இநஸத ஆரயஸசஸசலயல ஸ எனஸ பஙஸக எனஸன எனஸபனத அறலகவனஸ.  இநஸத
     ஆரடயஸசஸசலகஸக எனத #ழஒதஸதனழபஸனபயமஸ தரகவனஸ எனஸற உறதல
அளலகஸகலகறனஸ.
   பஙஸக சபறபவரலனஸ சபயரமஸ #கவரலயமஸ:
  பஙஸக சபறபவரலனஸ னகசயடபஸபமஸ / வலரலஸகரனக :
கததல:
சடடஸசல:
(  சடடஸசலயலனஸ சபயரஸ, #கவரல, னகசயடபஸபதஸதடனஸ)
   ஆரடயஸசஸசல சசயஸபவரலனஸ சபயரமஸ னகசயடபஸப#மஸ :
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1	   GURU	  BADHUR	   62	   M	   EUTHYROID	   MNG	   5055/15	   S-­‐FNAC	   5	   SIMPLE	  COLLOIDAL	  GOITRE	  
2	   BAKKIYAM	   40	   F	   HYPOTHYROID	   MNG	   3135/15	   S-­‐FNAC	   5	   COLLOIDAL	  GOITRE	  
3	   THANGA	  MANI	   55	   F	   EUTHYROID	   LT	  SNT	   1951/15	   S-­‐FNAC	   6	   COLLOID	  NODULE	  WITH	  	  CYSTIC	  DEGENERATION	  
4	   RUBINI	   19	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   1704/15	   S-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
5	   GAYATHIRI	   15	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3467/15	   S-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
6	   NAZEEMA	   35	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3463/15	   S-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
7	   VIJAYA	   40	   F	   EUTHYROID	   RT	  SNT	   3462/15	   S-­‐FNAC	   3	   COLLOIDAL	  GOITRE	  WITH	  CYSTIC	  CHANGE	  
8	   SELVI	   45	   F	   EUTHYROID	   MNG	   3433/15	   S-­‐FNAC	   8	   HASHIMOTOS	  THYROIDITIS	  
9	   VANITHA	   30	   F	   EUTHYROID	   RT	  SNT	   3449/15	   S-­‐FNAC	   5	   COLLOIDAL	  GOITRE	  
10	   SUMATHY	   41	   F	   EUTHYROID	   MNG	   3427/15	   S-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
11	   RAJESWARI	   42	   F	   EUTHYROID	   RT	  SNT	   3422/15	   S-­‐FNAC	   5	   COLLOIDAL	  GOITRE	  WITH	  CYSTIC	  CHANGE	  
12	   SARASWATHY	   60	   F	   EUTHYROID	   RT	  SNT	   3411/15	   S-­‐FNAC	   5	   COLLOID	  GOITRE	  
13	   MEGALA	   49	   F	   HYPOTHYROID	   RT	  SNT	   3390/15	   S-­‐FNAC	   6	   FOLLICULAR	  NEOPLASM	  OF	  UNDETERMINED	  SIGNIFICANCE	  
14	   SHANTHI	   32	   F	   HYPOTHYROID	   MNG	   3363/15	   S-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
15	   ESWARI	   30	   F	   HYPOTHYROID	   MNG	   3364/15	   S-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  CHANGES	  
16	   LATHA	  KRISHNAN	   40	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3360/15	   S-­‐FNAC	   8	   HASHIMOTOS	  THYROIDITIS	  
17	   LATHA	  	   35	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3359/15	   S-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
18	   VELUMANI	   30	   M	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3357/15	   S-­‐FNAC	   5	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  CHANGES	  
19	   MALA	  KONDAN	   63	   M	   EUTHYROID	   DIFFUSE	  GOITRE	   3354/15	   S-­‐FNAC	   7	   NODULAR	  COLLOID	  GOITRE	  
20	   VIJI	   25	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3508/15	   S-­‐FNAC	   5	   HASHIMOTOS	  THYROIDITIS	  
21	   KANAGAVALLI	   75	   F	   EUTHYROID	   MNG	   3521/15	   S-­‐FNAC	   7	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  CHANGES	  
22	   VICTORIA	   64	   F	   EUTHYROID	   MNG	   3537/15	   S-­‐FNAC	   8	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  CHANGES	  
23	   PARVATHI	   19	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3428/15	   S-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
24	   GEETHA	   62	   F	   EUTHYROID	   RT	  SNT	   3399/15	   S-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
25	   NIVETHA	   16	   F	   EUTHYROID	   MNG	   3396/15	   S-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
26	   MAHALAKSHMI	   31	   F	   HYPOTHYROID	   RT	  SNT	   3393/15	   USG-­‐FNAC	   7	   COLLOID	  GOITRE	  WITH	  CYSTIC	  CHANGES	  
27	   REGINI	   31	   F	   EUTHYROID	   RT	  SNT	   3386/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  
28	   VENKATESAN	   38	   M	   EUTHYROID	   MNG	   3380/15	   USG-­‐FNAC	   7	   MEDULLARY	  CARCINOMA	  THYROID	  
29	   PONNAMMAL	   65	   F	   EUTHYROID	   MNG	   3376/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  
30	   BAKYALAKSHMI	   15	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3353/15	   USG-­‐FNAC	   5	   HASHIMOTOS	  THYROIDITIS	  
31	   CHANDRA	  KANTHA	   32	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3349/15	   USG-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
32	   SANGEETHA	   28	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3345/15	   USG-­‐FNAC	   7	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
33	   DIVYA	   17	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3346/15	   USG-­‐FNAC	   8	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
34	   KRISHNA	  VENI	   48	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3344/15	   USG-­‐FNAC	   8	   HASHIMOTOS	  THYROIDITIS	  
35	   TAMIL	  ARASI	   34	   F	   EUTHYROID	   MNG	   3336/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
36	   SEMBARATHI	   23	   F	   EUTHYROID	   RT	  SNT	   3324/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
37	   KALPANA	   28	   F	   EUTHYROID	   LT	  SNT	   3321/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  
38	   RUCILLA	   31	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3318/15	   USG-­‐FNAC	   8	   HASHIMOTOS	  THYROIDITIS	  
39	   THOMNARAMMAL	   66	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3309/15	   USG-­‐FNAC	   4	   COLLOID	  GOITRE	  
40	   VALLIAMMAL	   63	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3258/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
41	   BHAVANI	   28	   F	   EUTHYROID	   RT	  SNT	   3254/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  
42	   SAKUNTHALA	   37	   F	   HYPOTHYROID	   MNG	   3241/15	   USG-­‐FNAC	   5	   NODULAR	  COLLOID	  GOITRE	  
43	   VIJAYA	   39	   F	   EUTHYROID	   LT	  SNT	   3239/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  
44	   VARALAKSHMI	   30	   F	   EUTHYROID	   LT	  SNT	   3237/15	   USG-­‐FNAC	   5	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
45	   RAJESWARI	   30	   F	   EUTHYROID	   LT	  SNT	   3236/15	   USG-­‐FNAC	   5	   COLLOID	  GOITRE	  
46	   INDRA	   25	   F	   EUTHYROID	   MNG	   3231/15	   USG-­‐FNAC	   5	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
47	   REVATHY	   23	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3227/15	   USG-­‐FNAC	   7	   COLLOID	  GOITRE	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48	   SABITHA	   40	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3214/15	   USG-­‐FNAC	   8	   HASHIMOTOS	  THYROIDITIS	  
49	   RISHWANA	  PARVEEEN	   22	   F	   EUTHYROID	   MNG	   3190/15	   USG-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
50	   ELAVARASI	   22	   F	   EUTHYROID	   MNG	   3186/15	   USG-­‐FNAC	   7	   HASHIMOTOS	  THYROIDITIS	  
51	   MUNIYAMMAL	   55	   F	   EUTHYROID	   RT	  SNT	   3181/15	   FNNAC	   8	   ADENOMATOID	  GOITRE	  
52	   PRISILLA	   18	   F	   HYPOTHYROID	   DIFFUSE	  GOITRE	   3177/15	   FNNAC	   8	   HASHIMOTOS	  THYROIDITIS	  
53	   PAVAMANI	   29	   F	   EUTHYROID	   MNG	   3123/15	   FNNAC	   5	   LYMPHOCYTIC	  THYROIDITIS	  
54	   CHINNAMMAL	   67	   F	   EUTHYROID	   MNG	   3120/15	   FNNAC	   8	   ADENOMATOID	  GOITRE	  
55	   GANDHI	  MATHI	   28	   F	   EUTHYROID	   MNG	   3118/15	   FNNAC	   5	   COLLOID	  GOITRE	  
56	   YASMIN	   16	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3111/15	   FNNAC	   5	   HASHIMOTOS	  THYROIDITIS	  
57	   SHENBAGA	  DEVI	   30	   F	   EUTHYROID	   RT	  SNT	   3110/15	   FNNAC	   5	   NODULAR	  COLLOID	  GOITRE	  WITH	  CYSTIC	  DEGENERATION	  
58	   MAGESWARI	   30	   F	   EUTHYROID	   RT	  SNT	   3562/15	   FNNAC	   3	   COLLOID	  GOITRE	  	  
59	   PUNITHA	   30	   F	   EUTHYROID	   DIFFUSE	  GOITRE	   3561/15	   FNNAC	   7	   COLLOID	  GOITRE	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                           ABSTRACT 
A  COMPARATIVE STUDY OF FINE NEEDLE ASPIRATION 
CYTOLOGY VERSUS FINE NEEDLE NON ASPIRATION CYTOLOGY 
VERSUS ULTRASOUND GUIDED FINE NEEDLE ASPIRATION 
CYTOLOGY IN THE CYTOLOGICAL EVALUATION OF THYROID 
LESIONS 
AIMS & OBJECTIVES: 
To evaluate the efficacy of fine-needle non-aspiration cytology (FNNAC) with 
that of standard  fine-needle aspiration cytology (FNAC)  and USG guided 
FNAC  of thyroid lesions as regards to cellular and hemorrhagic yield. 
MATERIALS AND METHODS: 
This study included 75 patients with thyroid lesions, out of which 25 cases 
underwent standard FNAC, 25 cases underwent FNNAC and 25 cases  
underwent USG guided FNAC. All the needle sampling procedures were  
performed by a single surgeon. The samples were then assessed  cytologically 
using five parameters .i.e., background blood or clot,amount of cellular 
material,degree of cellular degeneration,degree of cellular trauma and retention 
of architecture and further categorised as unsuitable,adequate and diagnostically 
superior for cytological evaluation.  
 
RESULTS: 
Analysis showed that  more number of diagnostically superior 
samples were obtained  from FNNAC technique(72%) than that of  
standard FNAC(44%), whereas FNAC yielded more number of 
diagnostically adequate samples(52%) than that of FNNAC(24%), 
diagnostically inadequate samples were equal with  both standard 
FNAC & FNNAC(4%). However, the diagnostic adequacy was equal 
in  both FNNAC and  standard FNAC techniques in thyroid lesions. 
On comparing FNNAC with that of USG guided FNAC, it was found 
that superior quality smears were  more in FNNAC technique(72%vs 
48%), but diagnostically adequate samples are more in USG guided 
FNAC than FNNAC(52% vs 24%). Also USG guided FNAC yielded 
fewer unsuitable smears. 
CONCLUSION: 
For highly vascular organs like thyroid , FNNAC is the preferred 
technique as there is better  material with less admixture of blood by 
yielding more  number of superior quality smears. The use of 
ultrasound enhances the diagnostic adequacy of FNAC by reducing 
the number of unsuitable smears obtained  in smaller and  cystic 
lesions. 
 
 
  
 
 
 
